EDMONTON, ALBERTA--(CCNMatthews - May 15, 2007) - BioMS Medical Corp. (TSX:MS), a leading developer of products for the treatment of multiple sclerosis (MS), today announced that it has entered into an underwriting agreement with a syndicate co-led by Orion Securities Inc. and Desjardins Securities Inc. and including Versant Partners Inc. Jefferies & Company, Inc., Janney Montgomery Scott LLC and Rodman & Renshaw, LLC are acting as U.S. placement agents in the offering on an exempt basis in the United States.
